We focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.

Use the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

There are currently no customer reviews or questions for Human anti-gp100 (aa280-288) T cell receptor (Affinity enhanced), pCDTCR1 (TCR-L029Z). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

To accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.

Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.

Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

The vector of anti-gp100 T cell receptor (TCR) is constructed for the engineering of T cell to target Human gp100. The T cells are genetically modified through transduction with a retroviral vector expressing gp100-specific T cell receptor. And the vector product was designed for the treatment of melanoma.